Please login to the form below

Not currently logged in
Email:
Password:

Karus names two division heads

Simon Roitt and Peter Finan strengthen research team

karus-Simon-RoittUK-based biopharma Karus Therapeutics has appointed new heads for two of its research divisions.

Dr Simon Roitt joins as head of clinical development and Dr Peter Finan joins as head of biology.

Dr Roitt (pictured right) is formerly director of clinical operations at Roche in the UK, a position he held for nine years. Prior to this he was director of clinical research at GE Healthcare in the UK.

His new colleague Dr Finan joins Karus from Novartis where he spent 16 years. Most recently he was VP, global head – respiratory disease.

In his new role Dr Finan will work on Karus' most advanced programme, a treatment for inflammatory disorders.

Dr Simon Kerry, chief executive of Karus said: “As we develop the business, the recruitment of highly experienced senior talent to our team will be a critical success factor. Simon and Peter both bring valuable clinical and scientific expertise to the Company, to help drive our programmes towards the clinic.”

29th October 2014

From: Research

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
An agency called Owen

We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster....

Latest intelligence

PME Jan cover
AstraZeneca’s focus on diagnosing and managing chronic kidney disease
People living with chronic kidney disease are in urgent need of new and improved approaches to diagnosis and care...
Delphi Technique Virtual Co-creation: A Customer Story
How a client leveraged the Delphi technique to co-create a consensus statement and algorithm using virtual touchpoints....
AI healthcare
Three ways AI will change healthcare in the next decade
Looking forward, there is no doubt that AI will continue to take centre stage in global healthcare initiatives...

Infographics